Signals From [Space]

Home
Kidneyverse
News
Q&A
Data Room
Careers
Archive
Leaderboard
About
Signals Brief: Why Lux Capital is Betting Big on CRISPR and the Future of Organ Transplants
eGenesis just raised $191M from a stellar group of investors betting on a future where 'dialysis becomes obsolete.'
 • 
Tim Fitzpatrick
A Hero’s Journey: How Balboa Nephrology Cultivates Patient-Centered Teams, with Kiku Boyance
"Over 120 of our dedicated staff engaged in learning, storytelling, and deep reflection on what it truly means to be an advocate for our patients."
 • 
Tim Fitzpatrick
 and 
Kiku Boyance
12:33
You're Doing it Wrong
Value-based Absurdism, Condition-Specific Bundles, and Getting it Right
Published on The Surgeon's Record • 

August 2024

Elliott Levy on career paths in nephrology, the puzzling nature of kidney diseases, and the elegance of clinical research
"We’re now able to target specific pathways in kidney disease that weren’t even identifiable a decade ago."
 • 
Tim Fitzpatrick
 and 
Jcnaeve
Signals Brief: Would you donate a kidney to a stranger... for $50,000?
We're one step closer to paying donors for their kidneys in the US. Here's how it would work, and why it might save taxpayers billions over the next…
 • 
Tim Fitzpatrick
5
Expert Q&A: Patient-Centric Kidney Innovation
How 7 patient advocates think about progress, pitfalls, and potential in this space
 • 
Tim Fitzpatrick
, 
Terry Litchfield
, 
Michael Gilchrist
, 
Vanessa Evans
, 
Karin Hehenberger
, and 
Fred Hill
Signals Brief: Protecting Patient Choice—The Ardelyx Lawsuit Against CMS and the Fight For Innovation Beyond The Bundle
How a lawsuit brought by Ardelyx, AAKP, and NMQF put phosphate binders front and center in the ongoing debate on paying for US kidney care
 • 
Tim Fitzpatrick
3

July 2024

Across the Kidneyverse: July, 2024
Living donor study, telemedicine trends, 1H 2024 funding, and more!
 • 
Tim Fitzpatrick
How to Invest Federal Funds Like a VC
"Nobody had done it before, so nothing like this existed"
Published on Statecraft • 
45:50
Signals Brief: The FTC's Antitrust Probe Into Big Dialysis & The State of Noncompetes in Healthcare
Why 40% of doctors and 30 million Americans might soon find themselves on level playing fields with their employers.
 • 
Tim Fitzpatrick
First Look: What 150+ Patients Say About the Dialysis Experience
A new survey sheds light on the realities of patient access, safety, and the financial and emotional impacts of dialysis.
 • 
Tim Fitzpatrick
3
We should probably talk about (barriers to) home dialysis
How the IM-HOME study reshapes our approach to patient, care partner, and provider-facing barriers to home dialysis.
 • 
Tim Fitzpatrick
6
© 2024 Tim Fitzpatrick
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great culture